Results 241 to 250 of about 123,112 (260)

Elevated tripeptidyl-peptidase 1 corrects multiple disease phenotypes in a mouse model of juvenile neuronal ceroid lipofuscinosis. [PDF]

Mol Ther Methods Clin Dev
Banach-Petrosky W, Larrimore KE, Sleat EH, Bazer A, Samuels B, Tan Y, Melton AC, Ichida JK, Logan TP, Lobel P, Sleat DE.   +10 more
europepmc   +1 more source

Cholesterol Ester Storage Disease in Two Field Spaniels With Lysosomal Acid Lipase Deficiency. [PDF]

J Vet Intern Med
Syrjä P, Ylenius MMH, Kråkström M, Dickens AM, Rautala E, Huupponen A, Eriksson A, Viitanen SJ.   +7 more
europepmc   +1 more source

GM2 Gangliosidosis AB Variant: A Hidden Truth. [PDF]

Cureus
Noites I, Coelho AS, Magalhães C, Ramos S, Laranjeira F, Lacerda L, Taipa R, Garrido C, Temudo T, Figueiroa S.   +9 more
europepmc   +1 more source

Management of Gaucher Disease Type 1 in a Resource-Limited Setting: A Pediatric Case Study. [PDF]

Clin Case Rep
Shah BK, Koirala D, Mishra B, Sapkota R, Basnet M.   +4 more
europepmc   +1 more source

Cell disorders in lysosomal storage diseases

, 2012
Élise Roy
openalex   +1 more source

Drug-Induced Reversible Lysosomal Changes Tracked in Live Cells by Holo-Tomographic Flow Cytometry. [PDF]

ACS Nano
Pirone D, Schiavo M, Giugliano G, Montefusco S, Miccio L, Memmolo P, Medina DL, Ferraro P.   +7 more
europepmc   +1 more source

Development of RNA based approaches to exploit alternative therapies for Lysosomal Storage Diseases

, 2018
Sandra Alvès
openalex   +1 more source